Latest Imugene News & Updates

See the latest news and media coverage for Imugene. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Imugene

Clinical-stage immuno-oncology company

imugene.com
Headquarters
Sydney, Australia
Founded year
2013
Company type
Public company
Number of employees
50–200

Last updated

Latest news about Imugene

In short: Imugene reported positive clinical data for its azer-cel therapy at ASCO 2026 and secured FDA Fast Track Designation for multiple blood cancers.

Company announcements

Imugene

Imugene's azer-cel achieves 81% overall response rate

Phase 1b dose expansion cohort in 19 relapsed/refractory blood cancer patients also showed 100% response in several subtypes.

Unlock all announcements with a

Media coverage

Yahoo Finance

Imugene doses first patient in BTKi combination cohort for azer-cel study

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has dosed the first patient in the Bruton Tyrosine Kinase inhibitor (BTKi) combination cohort of its Phase 1b azer-cel study...

Unlock all articles with a

Never miss news about Imugene

Track Imugene and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Imugene competitors & trending companies

Browse news for competitors to Imugene and other trending companies.